Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: Initial observations

Diego R Martin, Richard C. Semelka, Jae Joon Chung, N. Cem Balci, Kathy Wilber

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The purpose of this study was to assess the feasibility of sequential administration of 2 different MR imaging contrast agents using a single visit protocol to image focal liver abnormalities. Twenty-one patients with known or suspected liver lesions were included in the study. All patients received a bolus intravenous injection of gadolinium chelate (Gd) and dynamically enhanced imaging performed. The patients then received an injection of mangafodipir trisodium (Mn) contrast and a second scan performed with an average delay of 62 min after the Gd bolus injection. The images were evaluated to determine the appearance of liver lesions after administration of each contrast agent, and for evidence of prior Gd administration adversely affecting evaluation of images acquired after Mn administration. Focal liver lesions were present in 19 patients, including 8 with liver metastases, 1 with liver lymphoma, 6 with hemangiomas, 3 with focal nodular hyperplasia (FNH), and 1 with hepatic abscess. In 2 other patients no liver lesions were identified in either the post-Gd or post-Gd-post-Mn scans. All malignant lesions identified on the post-Gd scan were also identified on post-Gd-post-Mn scans. Although the potential benefit for increasing detection sensitivity for hepatic metastases was not demonstrated, this is a preliminary series. This study does demonstrate the practicality for use a single visit sequential Gd-Mn protocol described here, with possible application of this technique for further assessment of the utility of combining Gd and Mn for detection of liver metastases. (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)955-963
Number of pages9
JournalMagnetic Resonance Imaging
Volume18
Issue number8
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Gadolinium
gadolinium
chelates
liver
Liver
lesions
metastasis
injection
Contrast Media
Neoplasm Metastasis
Imaging techniques
Focal Nodular Hyperplasia
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
Liver Abscess
abnormalities
Injections
Hemangioma
Intravenous Injections
Lymphoma
evaluation

Keywords

  • Contrast agents
  • Gadolinium
  • Liver
  • Mangafodipir trisodium
  • Manganese

ASJC Scopus subject areas

  • Biophysics
  • Clinical Biochemistry
  • Structural Biology
  • Radiology Nuclear Medicine and imaging
  • Condensed Matter Physics

Cite this

Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions : Initial observations. / Martin, Diego R; Semelka, Richard C.; Chung, Jae Joon; Balci, N. Cem; Wilber, Kathy.

In: Magnetic Resonance Imaging, Vol. 18, No. 8, 2000, p. 955-963.

Research output: Contribution to journalArticle

Martin, Diego R ; Semelka, Richard C. ; Chung, Jae Joon ; Balci, N. Cem ; Wilber, Kathy. / Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions : Initial observations. In: Magnetic Resonance Imaging. 2000 ; Vol. 18, No. 8. pp. 955-963.
@article{84a5c226570f49db8099ec4030d6c87a,
title = "Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: Initial observations",
abstract = "The purpose of this study was to assess the feasibility of sequential administration of 2 different MR imaging contrast agents using a single visit protocol to image focal liver abnormalities. Twenty-one patients with known or suspected liver lesions were included in the study. All patients received a bolus intravenous injection of gadolinium chelate (Gd) and dynamically enhanced imaging performed. The patients then received an injection of mangafodipir trisodium (Mn) contrast and a second scan performed with an average delay of 62 min after the Gd bolus injection. The images were evaluated to determine the appearance of liver lesions after administration of each contrast agent, and for evidence of prior Gd administration adversely affecting evaluation of images acquired after Mn administration. Focal liver lesions were present in 19 patients, including 8 with liver metastases, 1 with liver lymphoma, 6 with hemangiomas, 3 with focal nodular hyperplasia (FNH), and 1 with hepatic abscess. In 2 other patients no liver lesions were identified in either the post-Gd or post-Gd-post-Mn scans. All malignant lesions identified on the post-Gd scan were also identified on post-Gd-post-Mn scans. Although the potential benefit for increasing detection sensitivity for hepatic metastases was not demonstrated, this is a preliminary series. This study does demonstrate the practicality for use a single visit sequential Gd-Mn protocol described here, with possible application of this technique for further assessment of the utility of combining Gd and Mn for detection of liver metastases. (C) 2000 Elsevier Science Inc.",
keywords = "Contrast agents, Gadolinium, Liver, Mangafodipir trisodium, Manganese",
author = "Martin, {Diego R} and Semelka, {Richard C.} and Chung, {Jae Joon} and Balci, {N. Cem} and Kathy Wilber",
year = "2000",
doi = "10.1016/S0730-725X(00)00198-3",
language = "English (US)",
volume = "18",
pages = "955--963",
journal = "Magnetic Resonance Imaging",
issn = "0730-725X",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions

T2 - Initial observations

AU - Martin, Diego R

AU - Semelka, Richard C.

AU - Chung, Jae Joon

AU - Balci, N. Cem

AU - Wilber, Kathy

PY - 2000

Y1 - 2000

N2 - The purpose of this study was to assess the feasibility of sequential administration of 2 different MR imaging contrast agents using a single visit protocol to image focal liver abnormalities. Twenty-one patients with known or suspected liver lesions were included in the study. All patients received a bolus intravenous injection of gadolinium chelate (Gd) and dynamically enhanced imaging performed. The patients then received an injection of mangafodipir trisodium (Mn) contrast and a second scan performed with an average delay of 62 min after the Gd bolus injection. The images were evaluated to determine the appearance of liver lesions after administration of each contrast agent, and for evidence of prior Gd administration adversely affecting evaluation of images acquired after Mn administration. Focal liver lesions were present in 19 patients, including 8 with liver metastases, 1 with liver lymphoma, 6 with hemangiomas, 3 with focal nodular hyperplasia (FNH), and 1 with hepatic abscess. In 2 other patients no liver lesions were identified in either the post-Gd or post-Gd-post-Mn scans. All malignant lesions identified on the post-Gd scan were also identified on post-Gd-post-Mn scans. Although the potential benefit for increasing detection sensitivity for hepatic metastases was not demonstrated, this is a preliminary series. This study does demonstrate the practicality for use a single visit sequential Gd-Mn protocol described here, with possible application of this technique for further assessment of the utility of combining Gd and Mn for detection of liver metastases. (C) 2000 Elsevier Science Inc.

AB - The purpose of this study was to assess the feasibility of sequential administration of 2 different MR imaging contrast agents using a single visit protocol to image focal liver abnormalities. Twenty-one patients with known or suspected liver lesions were included in the study. All patients received a bolus intravenous injection of gadolinium chelate (Gd) and dynamically enhanced imaging performed. The patients then received an injection of mangafodipir trisodium (Mn) contrast and a second scan performed with an average delay of 62 min after the Gd bolus injection. The images were evaluated to determine the appearance of liver lesions after administration of each contrast agent, and for evidence of prior Gd administration adversely affecting evaluation of images acquired after Mn administration. Focal liver lesions were present in 19 patients, including 8 with liver metastases, 1 with liver lymphoma, 6 with hemangiomas, 3 with focal nodular hyperplasia (FNH), and 1 with hepatic abscess. In 2 other patients no liver lesions were identified in either the post-Gd or post-Gd-post-Mn scans. All malignant lesions identified on the post-Gd scan were also identified on post-Gd-post-Mn scans. Although the potential benefit for increasing detection sensitivity for hepatic metastases was not demonstrated, this is a preliminary series. This study does demonstrate the practicality for use a single visit sequential Gd-Mn protocol described here, with possible application of this technique for further assessment of the utility of combining Gd and Mn for detection of liver metastases. (C) 2000 Elsevier Science Inc.

KW - Contrast agents

KW - Gadolinium

KW - Liver

KW - Mangafodipir trisodium

KW - Manganese

UR - http://www.scopus.com/inward/record.url?scp=0033659677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033659677&partnerID=8YFLogxK

U2 - 10.1016/S0730-725X(00)00198-3

DO - 10.1016/S0730-725X(00)00198-3

M3 - Article

C2 - 11121698

AN - SCOPUS:0033659677

VL - 18

SP - 955

EP - 963

JO - Magnetic Resonance Imaging

JF - Magnetic Resonance Imaging

SN - 0730-725X

IS - 8

ER -